Brought to you by:
Incorporation of Shockwave E8 Peripheral IVL into the treatment of patients with chronic limb-threatening ischemia
This advertorial is sponsored by Shockwave Medical. Anand Prasad, MD, an 18-year veteran of vascular and endovascular medicine with a particular interest in peripheral arterial disease (PAD) in patients with chronic kidney disease (CKD), explores the deliverability of the Shockwave…
New analysis probes BEST-CLI trial against real-world setting data
A new analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions (May 18–20) in Phoenix. Since the initial results of the BEST-CLI trial found surgery superior to…
End-stage CLTI: Deep-vein arterialization procedure demonstrates amputation-free survival rate of 66% at six months
Six-month results from the PROMISE II trial of the LimFlow deep-vein arterialization system showed an overall amputation-free survival of 66%—“well above” the primary endpoint target of 54%, chief investigator Daniel Clair, MD, told the 2022 Vascular Interventional Advances (VIVA) meeting…
BEST-CLI attracts $3.3m funding injection to continue data analysis
The Novo Nordisk Foundation has made a $3.3 million contribution toward the BEST-CLI (Best endovascular vs. best surgical therapy in patients with critical limb ischemia) clinical trial, the Denmark-based entity has announced. The grant is set to be used by investigators…
Positive two-year data from ALPS registry of LimFlow system published
LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialization (pDVA) system. Results were published online yesterday in the Journal of Endovascular Therapy and will also appear in the August print issue…
When world vascular societies combined to produce new global guidelines for CLTI
Four years ago, vascular experts from around the world were tasked with a quest to get all surgeons and providers to agree on the best ways to treat this common and debilitating illness: chronic limb-threatening ischemia (CLTI). The goal came…